Clinical Trials Logo

Citation(s)

Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - "RUSTY")

Details for clinical trial NCT00216762